BRIEF-Pharma Mar Receives FDA Clearance For Pm54 Platform Trial Starfish-54

1

Sept 23 (Reuters) – Pharma Mar SA: * RECEIVES FDA CLEARANCE FOR PM54 PLATFORM TRIAL STARFISH-54 TO ACCELERATE COMBINATION DEVELOPMENT ACROSS SOLID TUMORS Source text Further company coverage: (Gdansk

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)